💰

Biopharma SHAKTI Mission 2026

Biopharma SHAKTI Mission India 2026 — ₹10,000 Crore Biotech & Pharma Boost

2026 ✓Finance₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics researchLaunched: 2026Updated: May 2026
2 min read
Reviewed by Riya Sharma, Editor · Last verified: 2 May 2026
Written & fact-checked by Riya Sharma · Editor, Schemes In India
Last verified: · How we verify scheme facts

What is Biopharma SHAKTI Mission 2026?

Biopharma SHAKTI (Synergizing Healthcare, Advancement, Knowledge, Technology and Innovation) is a new ₹10,000 crore flagship mission announced in Union Budget 2026-27 to position India as a global biotech and biopharma leader. The mission focuses on accelerating vaccine development, biologics manufacturing, biosimilar production, and genomics research. It builds on India's existing Biotechnology Industry Research Assistance Council (BIRAC) infrastructure and the Ayushman Bharat Health Infrastructure Mission. The scheme provides grants, equity support, and subsidised loans to biotech startups, MSMEs, and large pharma companies investing in next-generation biologics, mRNA platforms, cell and gene therapy, and precision medicine. India's pharma industry — valued at $65 billion — is already the world's 3rd largest by volume; Biopharma SHAKTI targets making it #1 by 2030.

Biopharma SHAKTI Mission 2026 — Quick Overview

Scheme NameBiopharma SHAKTI Mission India 2026 — ₹10,000 Crore Biotech & Pharma Boost
Launched ByGovernment of India
Launch Year2026
Benefit₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics research
CategoryFinance
Last Verified2 May 2026
Official Portalhttps://birac.nic.in
🏴Hindi me Jankari

बायोफार्मा SHAKTI मिशन Union Budget 2026-27 का नया ₹10,000 करोड़ biotech & pharma scheme — vaccines, biologics, biosimilars, genomics, mRNA platforms। BIRAC + startups + MSMEs + large pharma को grants और subsidised loans। India को 2030 तक global pharma #1 बनाने का लक्ष्य।

₹10,000 करोड़ — grants, equity support, loans — biotech startups, pharma MSMEs, vaccine manufacturers, genomics, mRNA platforms

Benefits of Biopharma SHAKTI Mission 2026

₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics research

Who is Eligible for Biopharma SHAKTI Mission 2026?

  • Biotech and biopharma companies registered in India
  • Startups registered with DPIIT (for startup-specific windows)
  • MSMEs in pharma / biotech sector
  • Research institutions and academic spin-offs with technology readiness
  • Large pharma companies for manufacturing scale-up in biosimilars, vaccines, cell & gene therapy
  • Applications through BIRAC's call-for-proposals under specific thematic windows

Documents Required for Biopharma SHAKTI Mission 2026

0/6 documents ready

How to Apply for Biopharma SHAKTI Mission 2026 Online?

  1. 1birac.nic.in → Funding → Open Calls → Biopharma SHAKTI Mission पर जाएं
  2. 2BIRAC portal पर company / startup registration करें
  3. 3Specific thematic call के अनुसार project proposal तैयार करें
  4. 4Online application submit करें — concept note → full proposal (2-stage)
  5. 5Peer review और BIRAC committee evaluation
  6. 6Grant / equity agreement signing → milestone-based disbursement
🏛️

Official Government Portal

birac.nic.in is the only authorised application channel, and the government charges nothing there — never pay anyone to apply on your behalf.

🔗Apply on birac.nic.in
Share on WhatsAppHelp others find this scheme

Frequently Asked Questions — Biopharma SHAKTI Mission 2026

₹10,000 crore pool se grants (up to ₹50 crore per project for R&D), equity support (BIRAC co-investment), and subsidised loans. Focus on: vaccines, biosimilars, mRNA, cell & gene therapy, precision medicine, genomics.
📢 Get free scheme updates!
Join Telegram